Jaydev Thakkar was named chief operating officer and Milan Shah was appointed chief technology officer of Biofourmis
Over the last few years, there has appeared to be big interest on the part of biopharma in leveraging artificial intelligence (AI) and machine learning to improve trial design and speed up drug development. Another related category is digital therapeutics (DTx), which the Digital Therapeutics Alliance says, “deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage or treat a broad spectrum of physical, mental and behavioral conditions.”
FreshBlood Group’s Bob Finkel shares his thoughts on various industry topics including the youth vaping epidemic and the complexities in promoting CBD-based products.
I got into Healthcare six years ago and canvassed major events to gain a consensus on what the future held.